An open label phase II study of indisulam in combination with irinotecan in patients with metastatic colorectal cancer who have been previously treated with 5-fluorouracil/leucovorin [folinic acid] and oxaliplatin

Trial Profile

An open label phase II study of indisulam in combination with irinotecan in patients with metastatic colorectal cancer who have been previously treated with 5-fluorouracil/leucovorin [folinic acid] and oxaliplatin

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Oct 2006

At a glance

  • Drugs Indisulam; Irinotecan
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 12 Oct 2006 Status change
    • 26 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top